Qin Shi

772 total citations
28 papers, 380 citations indexed

About

Qin Shi is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Qin Shi has authored 28 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Qin Shi's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qin Shi is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Qin Shi collaborates with scholars based in China, United States and Hong Kong. Qin Shi's co-authors include Xiaoqing Yang, Yuquan Zhang, Baolan Sun, Zhan Zhou, Qiaolin Chen, Yao Jiang, Ling Xu, Lihua Qiu, Rong Yang and Min Su and has published in prestigious journals such as Annals of Oncology, Archives of Biochemistry and Biophysics and European Journal of Cancer.

In The Last Decade

Qin Shi

25 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qin Shi China 11 166 150 81 62 59 28 380
Nisreen Abu Shahin Jordan 12 138 0.8× 67 0.4× 62 0.8× 88 1.4× 39 0.7× 40 466
Meilian Dong China 10 121 0.7× 134 0.9× 172 2.1× 82 1.3× 51 0.9× 17 369
Andrea Biondo Italy 10 197 1.2× 34 0.2× 92 1.1× 22 0.4× 70 1.2× 29 394
John Liang United States 13 157 0.9× 50 0.3× 152 1.9× 52 0.8× 72 1.2× 28 470
Libing Xiang China 15 202 1.2× 127 0.8× 215 2.7× 59 1.0× 78 1.3× 43 615
Yu Yu Andreeva Russia 9 118 0.7× 68 0.5× 127 1.6× 18 0.3× 57 1.0× 70 351
Christian Lussier Canada 10 206 1.2× 65 0.4× 122 1.5× 27 0.4× 45 0.8× 16 408
H. A. Fritsche United States 7 95 0.6× 82 0.5× 166 2.0× 61 1.0× 83 1.4× 12 384
Romano Scalerta Italy 9 92 0.6× 96 0.6× 176 2.2× 77 1.2× 72 1.2× 16 372

Countries citing papers authored by Qin Shi

Since Specialization
Citations

This map shows the geographic impact of Qin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Shi more than expected).

Fields of papers citing papers by Qin Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Shi. The network helps show where Qin Shi may publish in the future.

Co-authorship network of co-authors of Qin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Qin Shi. A scholar is included among the top collaborators of Qin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qin Shi. Qin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Qin, Kexin Li, Hao Zheng, et al.. (2025). Retinal vascular alterations in cognitive impairment: A multicenter study in China. Alzheimer s & Dementia. 21(2). e14593–e14593. 2 indexed citations
2.
3.
Zhao, Ting, et al.. (2024). Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells. Molecular Medicine Reports. 30(1). 3 indexed citations
4.
Zhou, Caicun, Jingbo Chen, Long Wang, et al.. (2024). PL02.04 Phase 3 Study of Ivonescimab (AK112) vs. Pembrolizumab as First-line Treatment for PD-L1-positive Advanced NSCLC: Primary Analysis of HARMONi-2. Journal of Thoracic Oncology. 19(10). S1–S1. 15 indexed citations
5.
Lou, Yuqing, Qin Shi, Yanwei Zhang, et al.. (2022). Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals. Frontiers in Cell and Developmental Biology. 10. 840466–840466. 1 indexed citations
6.
Shi, Qin, et al.. (2022). [Mechanism of human airway epithelial cell injury induced by Candida albicans infection].. PubMed. 102(25). 1924–1930. 1 indexed citations
7.
Lü, Jun, Jun Wu, Yuqing Lou, et al.. (2022). Blood-based tumour mutation index act as prognostic predictor for immunotherapy and chemotherapy in non-small cell lung cancer patients. Biomarker Research. 10(1). 55–55. 10 indexed citations
8.
Shi, Qin, et al.. (2021). Exosome-shuttled miR-7162-3p from human umbilical cord derived mesenchymal stem cells repair endometrial stromal cell injury by restricting APOL6. Archives of Biochemistry and Biophysics. 707. 108887–108887. 25 indexed citations
9.
Shi, Qin, Qiaolin Chen, Zhan Zhou, et al.. (2021). Hypoxia-induced antizyme inhibitors 2 regulates cisplatin resistance through epithelia-mesenchymal transition pathway in non-small cell lung cancer. Pulmonary Pharmacology & Therapeutics. 69. 102048–102048. 5 indexed citations
10.
Shi, Qin, Jianqiang Yu, P. Andy Li, Xiaoli Lü, & Weiling Wang. (2021). MicroRNA-337 participates in the progression of early-stage diabetic retinopathy by upregulating MAP3K12. Minerva Medica. 113(6). 1038–1040. 1 indexed citations
11.
Yang, Xiaoqing, Yi Zhu, Qin Shi, et al.. (2021). Dipeptidyl peptidase IV is required for endometrial carcinoma cell proliferation and tumorigenesis via the IL‐6/STAT3 pathway. Journal of obstetrics and gynaecology research. 47(7). 2449–2459. 4 indexed citations
12.
13.
14.
15.
16.
Lü, Jun, Qin Shi, Lele Zhang, et al.. (2019). Integrated Transcriptome Analysis Reveals KLK5 and L1CAM Predict Response to Anlotinib in NSCLC at 3rd Line. Frontiers in Oncology. 9. 886–886. 19 indexed citations
17.
Shi, Qin, Jingwei Gao, Yao Jiang, et al.. (2017). Differentiation of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells into endometrial cells. Stem Cell Research & Therapy. 8(1). 246–246. 43 indexed citations
18.
Shi, Qin, et al.. (2017). MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1. Cancer Biomarkers. 20(4). 539–546. 57 indexed citations
19.
20.
Zhuang, Ming, Qin Shi, Xiuwei Zhang, et al.. (2014). Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. Tumor Biology. 36(4). 2737–2745. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nisreen Abu Shahin Breakdown of academic impact, for papers by Meilian Dong Breakdown of academic impact, for papers by Andrea Biondo Breakdown of academic impact, for papers by John Liang Breakdown of academic impact, for papers by Libing Xiang Breakdown of academic impact, for papers by Yu Yu Andreeva Breakdown of academic impact, for papers by Christian Lussier Breakdown of academic impact, for papers by H. A. Fritsche Breakdown of academic impact, for papers by Romano Scalerta
Rankless by CCL
2026